Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

A Novel Synthetic Cannabinoid Derivative Inhibits Inflammatory Liver Damage via Negative Cytokine Regulation

Iris Lavon, Tatiana Sheinin, Sigal Meilin, Efrat Biton, Ayelet Weksler, Gilat Efroni, Avi Bar-Joseph, George Fink and Ayelet Avraham
Molecular Pharmacology December 2003, 64 (6) 1334-1341; DOI: https://doi.org/10.1124/mol.64.6.1334
Iris Lavon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatiana Sheinin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sigal Meilin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Efrat Biton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayelet Weksler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilat Efroni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Avi Bar-Joseph
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Fink
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayelet Avraham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 64 no. 6 1334-1341
DOI 
https://doi.org/10.1124/mol.64.6.1334
PubMed 
14645663

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received May 16, 2003
  • Accepted September 5, 2003
  • Published online November 26, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Iris Lavon,
  2. Tatiana Sheinin,
  3. Sigal Meilin,
  4. Efrat Biton,
  5. Ayelet Weksler,
  6. Gilat Efroni,
  7. Avi Bar-Joseph,
  8. George Fink and
  9. Ayelet Avraham
  1. Pharmos Limited, Kiryat Weizmann, Rehovot, Israel
  1. Address correspondence to:
    Dr. Iris Lavon, Pharmos LTD, Kiryat Weizmann, Bld #13b, Rehovot 76326, Israel. E-mail: lavoni{at}netvision.net.il
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2003 to January 2021

AbstractFullPdf
Nov 2003431647
Dec 200370172137
Jan 2004439067
Feb 2004284933
Mar 2004345528
Apr 2004123514
May 2004113817
Jun 2004256925
Jul 2004355930
Aug 200429297
Sep 2004392411
Oct 2004282610
Nov 2004223615
Dec 2004172417
Jan 2005244219
Feb 2005205814
Mar 2005254324
Apr 2005183216
May 2005192318
Jun 2005132519
Jul 2005122621
Aug 2005142219
Sep 2005132014
Oct 2005141713
Nov 2005132111
Dec 2005132820
Jan 2006273922
Feb 200615134
Mar 2006152513
Apr 2006161915
May 2006332615
Jun 2006412314
Jul 2006152314
Aug 2006191415
Sep 2006441015
Oct 2006303018
Nov 2006222019
Dec 2006192314
Jan 2007292218
Feb 2007131414
Mar 2007162013
Apr 2007182315
May 2007122812
Jun 2007121813
Jul 2007102216
Aug 200714209
Sep 200714179
Oct 20077208
Nov 2007172321
Dec 200715356
Jan 2008251614
Feb 2008261613
Mar 2008591414
Apr 2008281510
May 200820108
Jun 200828189
Jul 200843118
Aug 200844153
Sep 200872177
Oct 200842147
Nov 2008341513
Dec 2008181110
Jan 2009261510
Feb 200915146
Mar 2009401614
Apr 20093794
May 2009222210
Jun 20092579
Jul 20092764
Aug 20091795
Sep 20092944
Oct 200932138
Nov 20093437
Dec 20091625
Jan 20103166
Feb 20102176
Mar 201029159
Apr 20102782
May 201032198
Jun 201016148
Jul 201021107
Aug 201025132
Sep 201025145
Oct 20101586
Nov 2010221212
Dec 201021116
Jan 2011141112
Feb 201112104
Mar 201112911
Apr 2011281827
May 2011111710
Jun 201118147
Jul 2011121610
Aug 201111812
Sep 201113159
Oct 20111989
Nov 2011181022
Dec 2011172814
Jan 20121558
Feb 20121868
Mar 2012171427
Apr 201216118
May 2012181914
Jun 20121088
Jul 2012231526
Aug 2012202111
Sep 201210129
Oct 201292212
Nov 201213918
Dec 201213208
Jan 2013282414
Feb 201347159
Mar 2013281311
Apr 2013272517
May 2013181812
Jun 201382316
Jul 20138132
Aug 20131192
Sep 2013881
Oct 201310171
Nov 201382015
Dec 2013151914
Jan 201422294
Feb 201420166
Mar 2014193510
Apr 201417138
May 20149138
Jun 20141243
Jul 20147213
Aug 20147142
Sep 201411166
Oct 201411184
Nov 2014222919
Dec 2014291012
Jan 201516113
Feb 201524124
Mar 201518149
Apr 20151491
May 201519285
Jun 201518234
Jul 201519206
Aug 201519162
Sep 201522166
Oct 20159134
Nov 2015121010
Dec 20159138
Jan 2016221310
Feb 20162276
Mar 201628913
Apr 201626410
May 201617128
Jun 2016271113
Jul 2016261312
Aug 2016271111
Sep 2016201310
Oct 201620128
Nov 2016231728
Dec 2016123016
Jan 20171506
Feb 20170332
Mar 20170733
Apr 20171591
May 20170605
Jun 20171464
Jul 20173734
Aug 201739312
Sep 201717214
Oct 20171658
Nov 201706830
Dec 201711076
Jan 201808110
Feb 20181924
Mar 20180985
Apr 20180632
May 20180745
Jun 201801192
Jul 201801386
Aug 20180551
Sep 20181534
Oct 20180370
Nov 201805014
Dec 201836101
Jan 20194300
Feb 20193201
Mar 20193500
Apr 20192200
May 20192900
Jun 20195804
Jul 20194210
Aug 20192810
Sep 20194320
Oct 20194310
Nov 20196201
Dec 20192900
Jan 20204100
Feb 20203421
Mar 20202200
Apr 20204911
May 20208132
Jun 20205610
Jul 20206000
Aug 20205120
Sep 20204840
Oct 20203531
Nov 20203920
Dec 20205262
Jan 20211931

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 64 (6)
Molecular Pharmacology
Vol. 64, Issue 6
1 Dec 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Novel Synthetic Cannabinoid Derivative Inhibits Inflammatory Liver Damage via Negative Cytokine Regulation
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

A Novel Synthetic Cannabinoid Derivative Inhibits Inflammatory Liver Damage via Negative Cytokine Regulation

Iris Lavon, Tatiana Sheinin, Sigal Meilin, Efrat Biton, Ayelet Weksler, Gilat Efroni, Avi Bar-Joseph, George Fink and Ayelet Avraham
Molecular Pharmacology December 1, 2003, 64 (6) 1334-1341; DOI: https://doi.org/10.1124/mol.64.6.1334

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

A Novel Synthetic Cannabinoid Derivative Inhibits Inflammatory Liver Damage via Negative Cytokine Regulation

Iris Lavon, Tatiana Sheinin, Sigal Meilin, Efrat Biton, Ayelet Weksler, Gilat Efroni, Avi Bar-Joseph, George Fink and Ayelet Avraham
Molecular Pharmacology December 1, 2003, 64 (6) 1334-1341; DOI: https://doi.org/10.1124/mol.64.6.1334
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • P2X7 Positive Modulator Structure-Activity Relationship
  • Predicting Drug Interactions with ENT1 and ENT2
  • GABAAR Molecular Identity in Oligodendrocytes
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics